Bio-Techne Corp (Germany) Performance
| TE1 Stock | 54.50 0.50 0.93% |
The firm shows a Beta (market volatility) of 0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bio-Techne Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio-Techne Corp is expected to be smaller as well. At this point, Bio Techne Corp has a negative expected return of -0.43%. Please make sure to confirm Bio-Techne Corp's accumulation distribution, day typical price, and the relationship between the skewness and rate of daily change , to decide if Bio Techne Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Bio Techne Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 199.1 M | |
| Free Cash Flow | 280.4 M |
Bio-Techne |
Bio-Techne Corp Relative Risk vs. Return Landscape
If you would invest 7,141 in Bio Techne Corp on December 13, 2024 and sell it today you would lose (1,691) from holding Bio Techne Corp or give up 23.68% of portfolio value over 90 days. Bio Techne Corp is generating negative expected returns and assumes 2.1049% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Bio-Techne, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bio-Techne Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio-Techne Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bio Techne Corp, and traders can use it to determine the average amount a Bio-Techne Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.203
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TE1 |
Estimated Market Risk
| 2.1 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bio-Techne Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio-Techne Corp by adding Bio-Techne Corp to a well-diversified portfolio.
Bio-Techne Corp Fundamentals Growth
Bio-Techne Stock prices reflect investors' perceptions of the future prospects and financial health of Bio-Techne Corp, and Bio-Techne Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio-Techne Stock performance.
| Current Valuation | 13.06 B | |||
| Price To Book | 7.56 X | |||
| Price To Sales | 12.34 X | |||
| Revenue | 1.11 B | |||
| EBITDA | 413.76 M | |||
| Total Debt | 243.41 M | |||
| Cash Flow From Operations | 325.27 M | |||
| Total Asset | 2.29 B | |||
About Bio-Techne Corp Performance
Assessing Bio-Techne Corp's fundamental ratios provides investors with valuable insights into Bio-Techne Corp's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bio-Techne Corp is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Bio Techne Corp performance evaluation
Checking the ongoing alerts about Bio-Techne Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Techne Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bio Techne Corp generated a negative expected return over the last 90 days |
- Analyzing Bio-Techne Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio-Techne Corp's stock is overvalued or undervalued compared to its peers.
- Examining Bio-Techne Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio-Techne Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio-Techne Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio-Techne Corp's stock. These opinions can provide insight into Bio-Techne Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.